Skip to main content
. 2023 Feb 14;13(9):5609–5618. doi: 10.1039/d2ra06859a

Fig. 4. The relative cell viability of 4T1 cells treated with different nanocapsules for different times. (a) HHSA@DOX, 12 h; (b) HHSA@DOX, 24 h; (c) HHSA@Ce6-DOX, 12 h; (d) HHSA@Ce6-DOX, 24 h. The concentration of different nanocapsules was calculated according to the concentration of HHSA.

Fig. 4